Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
6.96
+0.06 (0.87%)
Dec 20, 2024, 4:00 PM EST - Market closed
Treace Medical Concepts Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -61.52 | -49.53 | -42.82 | -20.55 | -3.67 | -4.27 |
| Depreciation & Amortization | 7.48 | 4.88 | 2.13 | 0.69 | 1.21 | 0.79 |
| Other Amortization | 0.77 | 0.77 | 0.24 | 0.18 | 0.22 | 0.15 |
| Asset Writedown & Restructuring Costs | - | - | 0.35 | - | 0.14 | - |
| Loss (Gain) From Sale of Investments | -1.29 | -1.41 | -0.13 | - | - | - |
| Stock-Based Compensation | 27.92 | 17.35 | 8.11 | 3.41 | 0.92 | 0.82 |
| Provision & Write-off of Bad Debts | 2.74 | 0.43 | 0.41 | 0.14 | 0.22 | 0.15 |
| Other Operating Activities | 1.42 | 2.67 | 6.86 | -0.07 | 0.64 | - |
| Change in Accounts Receivable | -1.92 | -9.3 | -11.04 | -4.23 | -4.29 | -6.02 |
| Change in Inventory | -14.3 | -9.85 | -8.77 | -2.74 | -2.26 | -2.81 |
| Change in Accounts Payable | 9.97 | 3.17 | 4.61 | 1.79 | 1.33 | -0.24 |
| Change in Other Net Operating Assets | -3.69 | 6.24 | 9.39 | 4.19 | 1.04 | 3.76 |
| Operating Cash Flow | -32.43 | -34.58 | -30.65 | -17.19 | -4.49 | -7.67 |
| Capital Expenditures | -10.77 | -11.46 | -14.84 | -2.71 | -1.07 | -1.21 |
| Cash Acquisitions | - | -20 | - | - | - | - |
| Investment in Securities | 47.73 | -49.84 | -61.68 | - | - | - |
| Investing Cash Flow | 36.96 | -81.3 | -76.52 | -2.71 | -1.07 | -1.21 |
| Short-Term Debt Issued | - | - | - | - | 1.79 | - |
| Long-Term Debt Issued | - | - | 53.5 | - | 29.53 | 20 |
| Total Debt Issued | - | - | 53.5 | - | 31.32 | 20 |
| Short-Term Debt Repaid | - | - | - | -1.79 | - | - |
| Long-Term Debt Repaid | - | - | -33.89 | - | -20 | - |
| Total Debt Repaid | - | - | -33.89 | -1.79 | -20 | - |
| Net Debt Issued (Repaid) | - | - | 19.61 | -1.79 | 11.32 | 20 |
| Issuance of Common Stock | 0.55 | 116.9 | 2.19 | 120.04 | 0.36 | 0.07 |
| Repurchase of Common Stock | -0.25 | -0.01 | - | - | - | - |
| Other Financing Activities | - | -7.5 | -0.99 | -10.6 | -0.18 | -0.33 |
| Financing Cash Flow | 0.3 | 109.38 | 20.81 | 107.65 | 11.5 | 19.74 |
| Net Cash Flow | 4.83 | -6.49 | -86.36 | 87.75 | 5.94 | 10.86 |
| Free Cash Flow | -43.2 | -46.03 | -45.49 | -19.9 | -5.56 | -8.88 |
| Free Cash Flow Margin | -21.29% | -24.60% | -32.07% | -21.07% | -9.70% | -22.54% |
| Free Cash Flow Per Share | -0.70 | -0.76 | -0.82 | -0.41 | -0.15 | -0.24 |
| Cash Interest Paid | 5.04 | 5.17 | 4.4 | 3.9 | 1.15 | 0.74 |
| Levered Free Cash Flow | -20.63 | -33.02 | -37.19 | -12.13 | -3.91 | - |
| Unlevered Free Cash Flow | -17.65 | -30.08 | -34.69 | -9.77 | -2.4 | - |
| Change in Net Working Capital | 3.94 | 9.29 | 8.32 | 0.84 | 3.99 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.